|Articles|May 15, 2014
- Pharmaceutical Technology-05-15-2014
- Volume 2014 eBook
- Issue 2
Potential Benefits Drive Interest in Continuous Manufacturing
Author(s)Cynthia A. Challener
Players across the biologics value chain are attracted by the advantages of continuous biopharmaceutical manufacturing.
Advertisement
Players across the biologics value chain are attracted by the advantages of continuous biopharmaceutical manufacturing.
Download
.
Articles in this issue
over 11 years ago
Continuous Bioprocessing Challengesover 11 years ago
Optimizing the Sterilization of Liquids in Sealed Containersover 11 years ago
Using Modular Systems in Biopharmaceutical Manufacturingover 11 years ago
Determining Protein Oxidation Induced During Fill-Finish Operationsover 11 years ago
Single-Use Technology in Parenteral Fill/FinishNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
The Year of AI: 2025’s Bio/pharma Upskilling Revolution
2
How GLP-1s, Digital Tech, and 505(b)(2) Strategies Are Reshaping the CDMO Landscape
3
Onshoring Requires a Plan for Training
4
Strategies for Building Pharmaceutical Supply Chain Resilience in a Shifting Market
5